Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AEHR +10.2% (also to acquire Incal Technologies), NTRS +3.5%, WAFD +1.9%, USB +1.2%
Other news:
- ORIC +11.5% (announces multiple collaborations to support ongoing trial evaluating ORIC-944)
- ACRS +9.7% (announces sale of OLUMIANT royalties and milestones to OMERS Life Sciences for up to $31.5 million)
- FTK +8.7% (EPA has designated the JP3 system as an approved measurement tech)
- GTES +7.8% (to join S&P SmallCap 600)
- BE +7.3% (forms partnership with CoreWeave to meet AI energy demands)
- FDMT +5.6% (Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Population Affirming Favorable Safety Profile and Robust Clinical Activity)
- ATHE +5% (interim data from the ATH434-202 open-label Phase 2 clinical trial)
- LGO +1.5% (reports Q2 production)
- GRIN +1.2% (announces court approval in respect of the selective capital reduction)